Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the previous Revision: v3.4.1 text and the government funding operating-status notice.SummaryDifference0.5%

- Check41 days agoChange DetectedA government funding lapse notice was added at the top of the page, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. The site revision version now shows v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedGlossary toggle added (Show glossary) and study record metadata updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; legacy labels and prior revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter changes: the HHS Vulnerability Disclosure link was removed and the Revision: v3.3.3 tag was added. These changes are limited to footer and metadata and do not affect the study content.SummaryDifference0.1%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.